Labiana Health S.A (LAB) | Stock Overview & Key Data
Labiana Health S.A. | Small-cap | Healthcare
Labiana Health S.A. | Small-cap | Healthcare
Labiana Health S.A Performance Comparison
Stock Range
Today's Range
Low: €3.90
High: €3.90
on August 8, 2025
52 Week Range
Low: €1.86
High: €4.00
on November 12, 2024
on July 23, 2025
All-Time High: €3.96 on July 10, 2025
Explore how other Spanish stocks compare to their 52-week ranges: View ES Market 52-Week Insights
Key Statistics
Market Cap
€28.2M
EPS
-0.16
P/E Ratio (TTM)
N/A
Forward P/E
4.33
P/B Ratio
5.86
PEG Ratio
N/A
Div. Yield
N/A
ROE
6.92%
Beta
-0.441
Debt to Equity
1,378.08
Financial Highlights
Profitability
Gross Margin
147.79%
Operating Margin
3.32%
Profit Margin
0.38%
Returns and Earnings
Return on Assets (TTM)
5.72%
Return on Equity (TTM)
6.92%
EBITDA
€3.3M
Net Income (TTM)
€253.5K
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€9.33
Quarterly Revenue Growth (YoY)
4.00%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Labiana Health S.A LAB | 28.16M Small-cap | 4.32% | 15.57% | 19.14% | 33.10% | 31.29% | 22.58% | 6,233.33% | 1,051.52% |
| Laboratorios ROVI | 2.72B Large-cap | -2.03% | -3.37% | 3.41% | -4.32% | -17.03% | -32.16% | 1.36% | 86.38% |
| Almirall S.A ALM | 2.20B Large-cap | -3.21% | -4.12% | 0.20% | 13.15% | 22.20% | 14.03% | 4.28% | 7.11% |
| Faes Farma S.A FAE | 1.31B Large-cap | -3.21% | -5.80% | -0.24% | 15.30% | 20.23% | 19.89% | 7.11% | 21.97% |
| Laboratorio Reig RJF | 240.10M Mid-cap | 2.03% | 1.68% | 1.00% | 14.83% | 17.51% | 9.49% | 8.70% | -20.84% |
| Grifols, S.A GRF | 7.93B Large-cap | -2.06% | 22.50% | 57.28% | 54.08% | 35.84% | 46.52% | -6.61% | -47.55% |
Ownership & Short Interest
Insider Ownership
71.69%
Institutional Ownership
0.11%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
18K
Average 90-Day Volume
9K
Labiana Health S.A Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Labiana Health S.A would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is LAB's 52-week high and low?
- In the last 52 weeks, Labiana Health S.A reached a high of €4.00 (on July 23, 2025) and a low of €1.86 (on November 12, 2024).
- What is the market cap and P/E ratio for LAB?
- Curious about Labiana Health S.A's size and valuation? Its market capitalization stands at 28.16M. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is 4.33.
- Does LAB pay dividends? If so, what's the yield?
- As for dividends, Labiana Health S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Labiana Health S.A's main competitors or similar companies to consider before investing?
When looking at Labiana Health S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Laboratorios
ROVI2.72B Healthcare Drug Manufacturers - Specialty & Generic -32.16% 1.36% Almirall S.A
ALM2.20B Healthcare Drug Manufacturers - Specialty & Generic 14.03% 4.28% Faes Farma S.A
FAE1.31B Healthcare Drug Manufacturers - Specialty & Generic 19.89% 7.11% Laboratorio Reig
RJF240.10M Healthcare Drug Manufacturers - Specialty & Generic 9.49% 8.70% Grifols, S.A
GRF7.93B Healthcare Drug Manufacturers - General 46.52% -6.61% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Labiana Health S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Labiana Health S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 6.92%, the Debt to Equity ratio from the most recent quarter is 1,378.08, and its Gross Profit Margin stands at 147.79%.
- What is the recent revenue and earnings growth for LAB?
- Looking at Labiana Health S.A's growth, its revenue over the trailing twelve months (TTM) was €67M. Compared to the same quarter last year (YoY), quarterly revenue grew by 4.00%, and quarterly earnings saw a YoY growth of N/A.
- How much of LAB stock is held by insiders and institutions?
- Wondering who owns Labiana Health S.A stock? Company insiders (like executives and directors) hold about 71.69% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.11%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.